Literature DB >> 30264208

Effect of Trocar Site Bupivacaine Administration, Time of First Passage of Flatus, and Duration of the Surgery on Postoperative Pain After Sleeve Gastrectomy: a Case Control Study.

Abdullah Sisik1, Hasan Erdem2.   

Abstract

INTRODUCTION: The effect of local anesthetic applications to trocar sites on postoperative pain control has been studied many times, and different results have been obtained. We planned a controlled study evaluating the effect of bupivacaine administration and other contributing factors on postoperative pain following sleeve gastrectomy.
MATERIAL AND METHODS: Patients who underwent laparoscopic sleeve gastrectomy were included in the study. Patients were randomized into two groups according to local application as either a local or non-local group. Also, the patients were grouped separately from local group allocation according to time to first passage of flatus (< 12 h, ≥ 12 h) and duration of surgery (> 50 min, ≤ 50 min). A visual analogue scale (VAS) was performed at 4, 8, 12, 24, and 48 h postoperatively. Opioid analgesics (pethidine HCl) were administered if the patient's VAS score was greater than 5. Demographic characteristics, such as age, gender, height, weight, body mass index (BMI), and operative time, were recorded. Demographic characteristics and VAS scores were compared between groups.
RESULTS: A total of 168 patients were included in the study. Of these, 84 patients were included in both of the local and non-local groups. The demographic characteristics between groups were similar. There was no significant difference between groups in terms of VAS scores (p > 0.05). In the analysis according to the time to first passage of flatus, the 48th-hour VAS scores were lower in the early flatus group (p = 0.036). According to the duration of surgery, first flatus was detected earlier, and VAS scores at the 8th and 12th hours were less in the short operation group (p < 0.001, p = 0.005, p = 0.031, respectively). DISCUSSION: Although we did not show any effect of local administration of bupivacaine in LSG on pain, we concluded that other factors like duration of surgery and first flatus time have an impact on this issue.

Entities:  

Keywords:  First passage of flatus; Postoperative pain; Trocar site bupivacaine

Mesh:

Substances:

Year:  2019        PMID: 30264208     DOI: 10.1007/s11695-018-3529-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  20 in total

1.  Pain sensitivity and pain scoring in patients with morbid obesity.

Authors:  Bart Torensma; Linda Oudejans; Monique van Velzen; Dingeman Swank; Marieke Niesters; Albert Dahan
Journal:  Surg Obes Relat Dis       Date:  2017-01-10       Impact factor: 4.734

2.  Effect of adding intrathecal morphine to a multimodal analgesic regimen for postoperative pain management after laparoscopic bariatric surgery: a prospective, double-blind, randomized controlled trial.

Authors:  Fatma Adel El Sherif; Ahmed Hassan Othman; Ahmad Mohammad Abd El-Rahman; Osama Taha
Journal:  Br J Pain       Date:  2016-09-15

3.  Does Preincisional Infiltration with Bupivacaine Reduce Postoperative Pain in Laparoscopic Bariatric Surgery?

Authors:  Rafael Moncada; Linas Martinaitis; Manuel Landecho; Fernando Rotellar; Carlos Sanchez-Justicia; Manuel Bellver; Magdalena de la Higuera; Camilo Silva; Beatriz Osés; Elena Martín; Susana Pérez; Jose Luis Hernandez-Lizoain; Gema Frühbeck; Victor Valentí
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

4.  Postoperative Opioid Requirements Following Roux-en-Y Gastric Bypass in Patients Receiving Continuous Bupivacaine Through a Pump System: A Retrospective Review.

Authors:  Andrew R Cohen; April N Smith; Brian S Henriksen
Journal:  Hosp Pharm       Date:  2013-06

5.  Randomized controlled double-blind trial of transversus abdominis plane block versus trocar site infiltration in gynecologic laparoscopy.

Authors:  Lena El Hachem; Ethan Small; Peter Chung; Erin L Moshier; Kathryn Friedman; Suzanne S Fenske; Herbert F Gretz
Journal:  Am J Obstet Gynecol       Date:  2014-08-01       Impact factor: 8.661

6.  Pre-incision local infiltration with levobupivacaine reduces pain and analgesic consumption after laparoscopic cholecystectomy: a new device for day-case procedure.

Authors:  F Cantore; L Boni; M Di Giuseppe; L Giavarini; F Rovera; G Dionigi
Journal:  Int J Surg       Date:  2008-12-24       Impact factor: 6.071

7.  Laparoscopic cholecystectomy pain: effects of the combination of incisional and intraperitoneal levobupivacaine before or after surgery.

Authors:  Işık Alper; Sezgin Ulukaya; Gülsüm Yüksel; Meltem Uyar; Taner Balcıoğlu
Journal:  Agri       Date:  2014

8.  Continuous infusion of intraperitoneal bupivacaine after laparoscopic surgery: a randomized controlled trial.

Authors:  Danny A Sherwinter; Amir M Ghaznavi; David Spinner; Richard H Savel; Jerzy M Macura; Harry Adler
Journal:  Obes Surg       Date:  2008-07-22       Impact factor: 4.129

9.  Intraperitoneal Ropivacaine Irrigation in Patients Undergoing Bariatric Surgery: a Prospective Randomized Clinical Trial.

Authors:  Jaime Ruiz-Tovar; Juan Gonzalez; Alejandro Garcia; Consuelo Cruz; Sara Rivas; Montiel Jimenez; Carlos Ferrigni; Manuel Duran
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

10.  Port site infiltration of local anesthetic after laparoendoscopic single site surgery for benign adnexal disease.

Authors:  Jung Eun Kim; Seung-Hyuk Shim; Meari Dong; Hyojin Lee; Han Sung Hwang; Han Sung Kwon; Sun Joo Lee; Ji Young Lee; In Sook Sohn; Soo-Nyung Kim; Soon-Beom Kang
Journal:  Obstet Gynecol Sci       Date:  2017-09-18
View more
  2 in total

1.  The Need to Control for Confounding Factors on Analgesic Studies Involving Bariatric Patients.

Authors:  Daniel Croxford; Mark C Kendall
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

2.  Risk Factors of Delayed Recovery of Gastrointestinal Function After Ileostomy Reversal for Rectal Cancer Patients.

Authors:  Lili Chu; Hui Wang; Suyu Qiu; Biyan Shao; Jia Huang; Qiyuan Qin; Yanjiong He; Jing Xue; Xiaoyan Li; Xiaoyan Huang; Rongkang Huang
Journal:  Cancer Manag Res       Date:  2021-06-29       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.